Next report date
≈
August 7
Report period
Q2 2025
EPS estimate
−0.51 CAD
Revenue estimate
4.51 M CAD
−1.69 CAD
−38.11 M CAD
14.63 M CAD
26.58 M
About PROFOUND MED CORP
Sector
Industry
CEO
Arun S. Menawat
Website
Headquarters
Mississauga
Founded
2008
FIGI
BBG0076T0BV5
Profound Medical Corp. is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the ablation of diseased tissue utilizing its platform technologies. The firm’s product, the TULSA-PRO system, combines real-time MRI, robotically driven transurethral sweeping action/thermal ultrasound, and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It is also focused on developing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases. The company was founded on June 13, 2008 and is headquartered in Mississauga, Canada.
−460%
−370%
−280%
−190%
−100%
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
−18.00 M
−12.00 M
−6.00 M
0.00
6.00 M
Revenue
Net income
Net margin %
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
−18.00 M
−12.00 M
−6.00 M
0.00
6.00 M
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
−18.00 M
−12.00 M
−6.00 M
0.00
6.00 M
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
−30.00 M
0.00
30.00 M
60.00 M
90.00 M
Debt
Free cash flow
Cash & equivalents
No news here
Looks like there's nothing to report right now
CDN stock PRN to seek entry into 25 dollar range!HI again! Good day! Taking long in PRN at 23.87 with a target of 25.60!
TLong

How does that look to you?To me, it. Looks like the down trend has ended. MFI is on the rise and has broken resistance. Vwmacd crossed up. Price broke above resistance.
What do you think?
TLong

CDN stock PRN to long tangle at fib!Hi! I'm hoping for a quick move inside this fib area of PRN! Long at 21.89 with a target of 23.80! I believe it has the muscle to maintain this continuation!
TLong

Trial Data offers Pennant/Flag breakout opportunity in PRN/PRFMFProfound Medical, a Canadian medical device company, traded on the Toronto Stock Exchange under the symbol PRN or PRFMF on the US exchange, has provided a nice Bullish Pennant/Flag formation. The pennant formation has formed over the last two months and broke out this morning on heavy volume, in re
Phase 3 trial data offers flag breakout opprotunity in PRN/PRFMFProfound Medical which is a Canadian company traded on the Toronto Stock Exchange under the symbol PRN or PRFMF on the US exchange, has provided a nice Bullish Pennant/Flag formation. The pennant formation has formed over the last two months and broke out this morning on heavy volume in reaction to
TLong

See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PRN is 6.95 CAD — it has decreased by −2.39% in the past 24 hours. Watch PROFOUND MED CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange PROFOUND MED CORP stocks are traded under the ticker PRN.
PRN stock has risen by 11.02% compared to the previous week, the month change is a 6.76% rise, over the last year PROFOUND MED CORP has showed a −36.82% decrease.
We've gathered analysts' opinions on PROFOUND MED CORP future price: according to them, PRN price has a max estimate of 16.74 CAD and a min estimate of 15.34 CAD. Watch PRN chart and read a more detailed PROFOUND MED CORP stock forecast: see what analysts think of PROFOUND MED CORP and suggest that you do with its stocks.
PRN stock is 3.60% volatile and has beta coefficient of 1.20. Track PROFOUND MED CORP stock price on the chart and check out the list of the most volatile stocks — is PROFOUND MED CORP there?
Today PROFOUND MED CORP has the market capitalization of 208.87 M, it has decreased by −9.67% over the last week.
Yes, you can track PROFOUND MED CORP financials in yearly and quarterly reports right on TradingView.
PROFOUND MED CORP is going to release the next earnings report on Aug 7, 2025. Keep track of upcoming events with our Earnings Calendar.
PRN earnings for the last quarter are −0.52 CAD per share, whereas the estimation was −0.41 CAD resulting in a −27.43% surprise. The estimated earnings for the next quarter are −0.51 CAD per share. See more details about PROFOUND MED CORP earnings.
PROFOUND MED CORP revenue for the last quarter amounts to 3.77 M CAD, despite the estimated figure of 4.79 M CAD. In the next quarter, revenue is expected to reach 4.51 M CAD.
PRN net income for the last quarter is −15.39 M CAD, while the quarter before that showed −6.92 M CAD of net income which accounts for −122.46% change. Track more PROFOUND MED CORP financial stats to get the full picture.
No, PRN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 25, 2025, the company has 142 employees. See our rating of the largest employees — is PROFOUND MED CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PROFOUND MED CORP EBITDA is −49.51 M CAD, and current EBITDA margin is −300.81%. See more stats in PROFOUND MED CORP financial statements.
Like other stocks, PRN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROFOUND MED CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PROFOUND MED CORP technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PROFOUND MED CORP stock shows the sell signal. See more of PROFOUND MED CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.